Our state-of-the-art sterile fill-finish and packaging site in Ridgefield, NJ, is dedicated to meeting the growing needs of biotech and pharma drug developers. With expanded capabilities in pre-filled syringe and liquid vial manufacturing, it helps to increase our U.S. capacity to manufacture the medicines patients rely on.
As part of Thermo Fisher Scientific’s global network of facilities, Ridgefield complements our world-class contract development and manufacturing services and strengthens our sterile fill-finish footprint—now spanning seven sites worldwide, including three in the U.S. (Greenville, NC; Plainville, MA; and Ridgefield, NJ).
Strategically located to streamline logistics and attract top talent along the East Coast, Ridgefield plays a vital role in the global pharmaceutical supply chain, with products distributed to more than 67 countries across all continents. With 360,000 sq. ft. of space, the site is well equipped to support sponsors of all sizes.
Facility overview:
- Total site: ~360,000 sq. ft.
- Manufacturing: ~80,000 sq. ft.
- Office space: ~50,700 sq. ft.
- Warehouse + cold storage: ~65,200 sq. ft. + 2,800 sq. ft.
- Packaging: ~8,800 sq. ft.s
Key capabilities:
- Hyaluronic acid manufacturing
- Viscous product filling
- Formulation
- Aseptic processing
- Terminal sterilization
- Filling 2 syringe lines, 1 vial line
- Integrated AVI and packaging 2 syringe lines, 1 vial line
- Global distribution
1125 Pleasant View Terrace,
Ridgefield, NJ 07657